Repligen
RGEN
#2045
Rank
S$12.03 B
Marketcap
S$213.80
Share price
-0.47%
Change (1 day)
12.28%
Change (1 year)
Categories

Repligen (RGEN) - Total assets

Total assets on the balance sheet as of September 2025 : S$3.78 Billion

According to Repligen 's latest financial reports the company's total assets are S$3.78 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Repligen - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$3.84 B2.87%
2023-12-31S$3.73 B10.17%
2022-12-31S$3.39 B6.45%
2021-12-31S$3.18 B26.65%
2020-12-31S$2.51 B33.37%
2019-12-31S$1.88 B78.37%
2018-12-31S$1.05 B6.41%
2017-12-31S$0.99 B137.83%
2016-12-31S$0.41 B102.14%
2015-12-31S$0.20 B22.03%
2014-12-31S$0.16 B12.77%
2013-12-31S$0.15 B26.71%
2012-12-31S$0.11 B
2011-03-31S$91.09 M-8.72%
2010-03-31S$99.79 M-10.92%
2009-03-31S$0.11 B18%
2008-03-31S$94.94 M115.24%
2007-03-31S$44.11 M-5.22%
2006-03-31S$46.54 M1.66%
2005-03-31S$45.78 M-7.47%
2004-03-31S$49.47 M4.58%
2003-03-31S$47.31 M-11.98%
2002-03-31S$53.74 M-7.9%
2001-03-31S$58.35 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novavax
NVAX
S$1.52 B-59.64%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$9.86 B 160.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$5.52 B 45.90%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$166.19 B 4,286.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$133.50 B 3,423.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$125.55 B 3,213.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$270.49 B 7,039.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$3.27 B-13.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$0.11 B-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
S$9.73 B 157.00%๐Ÿ‡บ๐Ÿ‡ธ USA